Dr. Howard Smith Reports

Howard G. Smith MD, AM

Howard G. Smith MD, AM has been reporting health and wellness news for more than 40 years on radio and via podcasts. Harvard Medical School, MD; Harvard University, AM, Immunology; former Medical Editor, WBZ-AM, Boston. Website: http://www.drhowardsmith.com Email: drhowardsmith.reports@gmail.com

  1. 4D AGO

    More Lung Cancer In Never Smokers

    Vidcast:  https://www.instagram.com/p/DVMiQvSjXbc/ Lung cancer is the leading cause of cancer deaths in the US. This cancer is on the rise among people who have never smoked, and more women than men are affected.  It’s a distinct disease that demands its own screening strategy. That’s the warning from investigators at University College London, published in the journal Trends in Cancer. Their concern stems from a meta-analysis of major global cancer datasets and prior screening trials. Heightened risk involve a combination of genetics, gender, family history, air pollution, radon or radiation exposure, and second hand smoke.  This latter exposure increases lung cancer risk for these non-smokers by approximately 20 to 25 percent.  Diagnosing and treating lung cancer early enough to prevent mortality requires screening.  In the case of heavy smokers, CT lung imaging yields a 20 percent reduction in mortality, but never-smokers typically do not qualify for this screening study under current guidelines.  The bottom line: never smokers, and that is now close to 90% of us, should undergo periodic lung imaging if there is an adverse genetic marker such as EGFR mutations, a strong family history, a history of air pollution exposure including exposure to second hand smoke, or documented radon exposure. Ask your medical team to see if you qualify and then get the imaging. https://www.cell.com/trends/cancer/fulltext/S2405-8033(25)00315-2 https://www.news-medical.net/news/20260215/Why-lung-cancer-in-never-smokers-is-rising-and-how-targeted-detection-could-reduce-deaths.aspx #cancer #lung #smoking #pollution #screening

    2 min
  2. 4D AGO

    Mini Lab-Grown Spinal Cords Test Repair Therapy

    Vidcast:  https://www.instagram.com/p/DVMh-JLjONk/ Regenerative nanomedicine researchers now report the successful regrowth of spinal cord nerve fibers while minimizing the interference of scar tissue. This from Northwestern University and published in the journal Nature Biomedical Engineering. Investigators there engineered millimeter-scale human spinal cord organoids from stem cells and incorporated in them functional neurons. They added astrocytes and microglial immune cells in order to study repair and inflammatory processes. Using this model, the team studied two types of traumatic injury models: a laceration injury and a compression injury. Batches of these damaged mini spinal cord organoids were treated with two types of therapeutic peptides; fast-moving supramolecules; and slower-moving versions containing the same biological signals. The slow movers drive neural regeneration while the fast movers stifle excess inflammation. The results are striking: the treated mini-spinal cords show substantial neural regeneration with nerve extension regrowth and the notable absence of glial scar tissue. These peptide agents had shown remarkable benefits in prior animal studies.  A single injection given 24 hours after severe injury enabled mice to walk again within four weeks. This lab-grown spinal cord model demonstrates the reason for this success. Spinal cord injuries cause permanent paralysis because scar tissue blocks effective nerve regrowth. Using lab-grown mini-spinal cord tissue, this study shows that molecular therapy can reduce inflammation, shrink scar tissue, and trigger functional nerve growth. Once these techniques are refined and subjected to clinical trials, the possibility of restoring limb use after otherwise devastating spinal cord injuries could come…..someday soon. https://www.sciencedaily.com/releases/2026/02/260216044003.htm https://www.nature.com/articles/s41551-025-01606-2 #spinalcord #paraplegia #quadraplegia #peptides #organoids s

    2 min
  3. 4D AGO

    Studying Gas-Passing

    Vidcast:  https://www.instagram.com/p/DVMg57wD-s3/ Medical science has reached a new height. We now have the first wearable device that can actually measure human flatulence, farts, in real time. The research fartologists are actually University of Maryland cell and molecular biologists who now publish their gaseous findings in the journal Biosensors and Bioelectronics. Their study tested “smart underwear” with a wearable sensor that measures the hydrogen gas produced by bacterial fermentation in the gut. Farts also contain an abundance of nitrogen and carbon dioxide, but these are provided by swallowed air and not generated in the gastrointestinal tract. In the 19 healthy adult subjects who wore the smart underwear about 11 hours a day for one week, researchers found flatulence occurs on average about 32 times per day. Individual variation was wide from as few as 4 events to as many as 59 per day. Compare this finding with older medical estimates of about 14 farts per day plus or minus. The device demonstrated 94.7% sensitivity in detecting increased hydrogen production after participants ate inulin, a prebiotic fiber known to stimulate the production of gut bacteria. This precise gas monitoring won’t cure cancer, but it is possible that a gastrointestinal cancer may have a very specific flatulence signature.  This technology will help establish a normal baseline for flatulence, something that has never existed before. Because the hydrogen in flatus is produced by gut bacteria, these measurements will provide insight into the effects of diet and microbiome activity on many digestive disorders.  https://www.acsh.org/news/2026/02/21/university-maryland-toots-out-beauty-smart-underwear-measures-your-farts-49967 https://www.sciencedirect.com/science/article/pii/S2590137025001268 #flatulence #farts #gastrointestinal

    2 min

About

Howard G. Smith MD, AM has been reporting health and wellness news for more than 40 years on radio and via podcasts. Harvard Medical School, MD; Harvard University, AM, Immunology; former Medical Editor, WBZ-AM, Boston. Website: http://www.drhowardsmith.com Email: drhowardsmith.reports@gmail.com